Related Experiment Video
Updated: May 3, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Comprehensive microRNA profiling of prostate cancer cells after ionizing radiation treatment
Chung-Man Leung1, Sung-Chou Li2, Ting-Wen Chen3
1Department of Radiation Oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.
Abstract:
MicroRNAs (miRNAs) are small, non-coding RNAs that negatively regulate gene expression and have emerged as potential biomarkers in radiation response to human cancer. Only a few miRNAs have been identified in radiation response to prostate cancer and the involvement of the radiation-associated miRNA machinery in the response of prostate cancer cells to radiation is not thoroughly understood. Therefore, the purpose of the present study was to comprehensively investigate the expression levels, arm selection preference and isomiRs of radiation-response miRNAs in radiation-treated PC3 cells using a next-generation sequencing (NGS) approach. Our data revealed that the arm selection preference and 3' modification of miRNAs may be altered in prostate cancer after radiation exposure. In addition, the proportion of AA dinucleotide modifications at the end of the read gradually increased in a time-dependent manner after PC3 radiation treatment. We also identified 6 miRNAs whose expression increased and 16 miRNAs whose expression decreased after exposure to 10 Gy of radiation. A pathway enrichment analysis revealed that the target genes of these radiation-induced miRNAs significantly co-modulated the radiation response pathway, including the mitogen-activated protein kinase (MAPK), Wnt, transforming growth factor-β (TGF-β) and ErbB signaling pathways. Furthermore, analysis of The Cancer Genome Atlas (TCGA) database revealed that the expression of these radiation-induced miRNAs was frequently dysregulated in prostate cancer. Our study identified radiation-induced miRNA candidates which may contribute to radiosensitivity and can be used as biomarkers for radiotherapy.
Insights
This study reveals radiation-induced microRNAs (miRNAs) in prostate cancer cells, identifying potential biomarkers for radiotherapy response and understanding miRNA machinery in cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression and potential biomarkers for cancer radiation response.
- Limited understanding exists regarding miRNA involvement in prostate cancer's response to radiation therapy.
Purpose of the Study:
- To comprehensively investigate miRNA expression, arm selection, and isomiRs in radiation-treated prostate cancer cells (PC3).
- To identify novel radiation-induced miRNA candidates and their associated pathways in prostate cancer.
Main Methods:
- Utilized next-generation sequencing (NGS) to analyze miRNA profiles in radiation-treated PC3 cells.
- Performed pathway enrichment analysis and examined The Cancer Genome Atlas (TCGA) database for miRNA dysregulation in prostate cancer.
Main Results:
- Radiation exposure altered miRNA arm selection and 3' modifications in PC3 cells.
- Identified 6 upregulated and 16 downregulated miRNAs post-10 Gy radiation.
- Radiation-induced miRNAs target key pathways (MAPK, Wnt, TGF-β, ErbB) involved in cellular response to radiation.
- Dysregulated miRNA expression was frequently observed in prostate cancer patients via TCGA analysis.
Conclusions:
- Identified specific radiation-induced miRNAs in prostate cancer.
- These miRNAs may play a role in radiosensitivity and serve as potential biomarkers for radiotherapy.
- Findings enhance understanding of miRNA machinery in prostate cancer radiation response.
Related Concept Videos
MicroRNAs
MicroRNAs

